Product Information
EUCRISA 2% OINTMENT is a brand product labeled by Pfizer Inc., priced at $10.7089 per GM under NDC 55724021111. Its NADAC has been published 355 times since Dec 18, 2019.
FDA first approved this application on Dec 14, 2016.
Strength
20 mg/g
Manufacturer
Pfizer Inc.NDC
55724021111
Classification
Brand
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CRISABOROLEApproval Type
New Drug (NDA)
FDA Application
NDA207695FDA Approved
12/14/2016
On Market Since
1/30/2017
Pharmacological Classes
Price Statistics
The NADAC for EUCRISA 2% OINTMENT has been published 355 times since Dec 18, 2019, and over the history we have for it it has risen 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.7089 per GM |
|---|---|
| All-time high | $10.7153 (Jun 11, 2025) |
| All-time low | $9.0052 (Dec 18, 2019) |
| 52-week high | $10.7089 |
| 52-week low | $10.6774 |
| Median price | $9.8358 |
| Average price | $9.8206 |
| Largest weekly change | +5.0% (Jan 4, 2023) |
| Weeks tracked | 355 |
| Tracking since | Dec 18, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
crisaborole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 4 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EUCRISA 2% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for EUCRISA 2% OINTMENT, manufactured by Pfizer Inc., is $10.7089 per GM (NDC 55724021111), effective Sep 30, 2026.
How has the price of EUCRISA 2% OINTMENT changed over time?
Over the history we have for it, the NADAC for EUCRISA 2% OINTMENT has risen 18.9%. It has been tracked across 355 weekly CMS publications since Dec 18, 2019.
What are the highest and lowest recorded NADAC prices for EUCRISA 2% OINTMENT?
Since Dec 18, 2019, the NADAC for EUCRISA 2% OINTMENT has ranged from a low of $9.0052 (Dec 18, 2019) to a high of $10.7153 (Jun 11, 2025), with a median of $9.8358 per GM.
Are there cheaper alternatives to EUCRISA 2% OINTMENT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EUCRISA 2% OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures EUCRISA 2% OINTMENT?
EUCRISA 2% OINTMENT (NDC 55724021111) is labeled by Pfizer Inc., and CMS classifies it as a brand product.